QIAGEN to Acquire SABiosciences
QIAGEN NV announces that it has signed a definite agreement to acquire SABiosciences Corp, a privately-held developer and manufacturer of disease- and pathway-focused PCR assay panels.
Read MoreQIAGEN NV announces that it has signed a definite agreement to acquire SABiosciences Corp, a privately-held developer and manufacturer of disease- and pathway-focused PCR assay panels.
Read MoreThat’s the question users of glucose monitors and other point-of-care (POC) tests may ask, according to a leading health care market research publisher.
Read MoreChina Medical Technologies Inc, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe from the State Food and Drug Administration of China (SFDA).
Read MoreAdeona Pharmaceuticals Inc announced today that it has initiated the US launch of its high precision diagnostic test panel for the comprehensive evaluation of zinc and copper status in patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI).
Read MoreThe Marketplace Review is available as a downloadable pdf – you will need Adobe Acrobat reader to view this. If you do not have Adobe Acrobat on your computer, you can download it for free from Adobe.com.
Read More